Comparison of metabolic effects of EGF, TGF-α, and TGF-β1 in primary culture of fetal bovine myoblasts and rat L6 myoblasts

[1]  T. Motyl,et al.  Mitogenic effect of lymph, amniotic and allantoic fluid in bovine fetal myoblasts. , 1993, Zentralblatt fur Veterinarmedizin. Reihe A.

[2]  S. Butterwith,et al.  Effects of transforming growth factor-alpha on chicken adipocyte precursor cells in vitro. , 1992, The Journal of endocrinology.

[3]  J. Bartlett,et al.  Growth control by epidermal growth factor and transforming growth factor-alpha in human lung squamous carcinoma cells. , 1992, British Journal of Cancer.

[4]  S. Langdon,et al.  Mitogenic effects of epidermal growth factor and transforming growth factor-alpha on EGF-receptor positive human ovarian carcinoma cell lines. , 1992, European journal of cancer.

[5]  H. Moses,et al.  The beta-type transforming growth factor. Mediators of cell regulation in the lung. , 1990, The American review of respiratory disease.

[6]  T. Fleming,et al.  Retroviral expression of transforming growth factor-alpha does not transform fibroblasts or keratinocytes. , 1990, The Journal of investigative dermatology.

[7]  H. Moses,et al.  The beta-type transforming growth factor , 1990 .

[8]  Gary R. Grotendorst,et al.  TGF‐β stimulates primary human skin fibroblast DNA synthesis via an autocrine production of PDGF‐related peptides , 1989 .

[9]  O. Koldovský.  Is breast-milk epidermal growth factor biologically active in the suckling? , 1989, Nutrition.

[10]  U. Marti,et al.  Biological effects of epidermal growth factor, with emphasis on the gastrointestinal tract and liver: An update , 1989, Hepatology.

[11]  D. Fisher,et al.  Epidermal growth factor and the kidney. , 1989, Annual review of physiology.

[12]  K. Kasai,et al.  Human urinary epidermal growth factor: effects of age, sex and pregnancy. , 1989, Hormone research.

[13]  R. Derynck,et al.  Developmental expression of transforming growth factors alpha and beta in mouse fetus , 1988, Molecular and cellular biology.

[14]  M. Sporn,et al.  Transforming growth factor-,B: possible roles incarcinogenesis* , 1988 .

[15]  R. Coffey,et al.  Growth modulation of mouse keratinocytes by transforming growth factors. , 1988, Cancer research.

[16]  R. Derynck,et al.  The human transforming growth factor type alpha coding sequence is not a direct-acting oncogene when overexpressed in NIH 3T3 cells. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[17]  J. Massagué.  The TGF-β family of growth and differentiation factors , 1987, Cell.

[18]  R. Derynck,et al.  Evidence that transforming growth factor-β is a hormonally regulated negative growth factor in human breast cancer cells , 1987, Cell.

[19]  M. Sporn,et al.  Transforming growth factor-beta: potential common mechanisms mediating its effects on embryogenesis, inflammation-repair, and carcinogenesis. , 1987, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.

[20]  J. Harper,et al.  Changes in protein metabolism of ovine primary muscle cultures on treatment with growth hormone, insulin, insulin-like growth factor I or epidermal growth factor. , 1987, The Journal of endocrinology.

[21]  J. Massagué,et al.  Type beta transforming growth factor is an inhibitor of myogenic differentiation. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[22]  G. Spizz,et al.  Regulation of myogenic differentiation by type beta transforming growth factor , 1986, The Journal of cell biology.

[23]  E. Rozengurt.  Early signals in the mitogenic response. , 1986, Science.

[24]  S. Schwartz,et al.  Inhibition of endothelial regeneration by type-beta transforming growth factor from platelets. , 1986, Science.

[25]  D. Goeddel,et al.  Expression in rat fibroblasts of a human transforming growth factor-α cDNA results in transformation , 1986, Cell.

[26]  H. Moses,et al.  Induction of c-sis mRNA and activity similar to platelet-derived growth factor by transforming growth factor beta: a proposed model for indirect mitogenesis involving autocrine activity. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[27]  D. Twardzik.  Differential expression of transforming growth factor-alpha during prenatal development of the mouse. , 1985, Cancer research.

[28]  David C. Lee,et al.  Cloning and sequence analysis of a cDNA for rat transforming growth factor-α , 1985, Nature.

[29]  M. Sporn,et al.  Type beta transforming growth factor: a bifunctional regulator of cellular growth. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[30]  Anita B. Roberts,et al.  Autocrine growth factors and cancer , 1985, Nature.

[31]  J. D. Etlinger,et al.  Inhibition of intracellular proteolysis in muscle cultures by multiplication-stimulating activity. Comparison of effects of multiplication-stimulating activity and insulin on proteolysis, protein synthesis, amino acid uptake, and sugar transport. , 1984, The Journal of biological chemistry.

[32]  B. Festoff,et al.  Regulation of mitotic activity and the cell cycle in primary chick muscle cells by neurotransferrin , 1984, Journal of cellular physiology.

[33]  J. Massagué,et al.  Epidermal growth factor-like transforming growth factor. II. Interaction with epidermal growth factor receptors in human placenta membranes and A431 cells. , 1983, The Journal of biological chemistry.

[34]  J. Mendelsohn,et al.  Growth stimulation of A431 cells by epidermal growth factor: identification of high-affinity receptors for epidermal growth factor by an anti-receptor monoclonal antibody. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[35]  F. Ballard,et al.  Effects of anabolic agents on protein breakdown in L6 myoblasts. , 1983, The Biochemical journal.

[36]  J. Arnold,et al.  Insulin stimulation of protein synthesis in cultured skeletal and cardiac muscle cells. , 1982, The American journal of physiology.

[37]  D. Twardzik,et al.  Human term placenta contains transforming growth factors. , 1982, Biochemical and biophysical research communications.

[38]  J. Florini,et al.  Effects of the somatomedins and insulin on myoblast differentiation in vitro. , 1981, Developmental biology.

[39]  B. Sanwal,et al.  A synergistic effect of glucocorticoids and insulin on the differentiation of myoblasts , 1980, Journal of cellular physiology.

[40]  J. Florini,et al.  Effect of rat age on blood levels of somatomedin-like growth factors. , 1980, Journal of gerontology.

[41]  D. Turner,et al.  Differentiation in cultures derived from embryonic chicken muscle: the postmitotic, fusion-capable myoblast as a distinct cell type. , 1978, Differentiation; research in biological diversity.

[42]  G. Carpenter,et al.  125I-labeled human epidermal growth factor. Binding, internalization, and degradation in human fibroblasts , 1976, The Journal of cell biology.

[43]  S. Hauschka.  Clonal analysis of vertebrate myogenesis. 3. Developmental changes in the muscle-colony-forming cells of the human fetal limb. , 1974, Developmental biology.

[44]  J. Abbott,et al.  The phenotypic complexity of myogenic clones. , 1974, Proceedings of the National Academy of Sciences of the United States of America.

[45]  D. Yaffe,et al.  Cellular aspects of muscle differentiation in vitro. , 1969, Current topics in developmental biology.

[46]  D. Yaffe.  Retention of differentiation potentialities during prolonged cultivation of myogenic cells. , 1968, Proceedings of the National Academy of Sciences of the United States of America.

[47]  I. Konigsberg.  Clonal Analysis of Myogenesis: Its relevance to the general problem of the stability of cell-type in cultured animal cells is discussed , 1963 .